The ITA reports that kickboxer Shukhratova Rukhshona has agreed¹ to the consequences for her anti-doping rule violation (ADRV).
The kickboxer provided a sample collected during an unannouced in-competiton doping control performed on 11 April 2025, which yielded an adverse analytical finding² (AAF) for furosemide. Furosemide is listed under class S5. Diuretics and Masking Agents according to the prohibited list of the World Anti-Doping Agency (WADA). It is prohibited at all times (in- and out-of-competition) and is classified as a specified substance. Furosemide can be used by athletes to excrete water for rapid weight loss.
The athlete did not challenge the ADRV and agreed with the consequences proposed by the ITA. Accordingly, the case was resolved via and acceptance of consequences.
The athlete’s period of ineligibility is from 23 May 2025 (date of the provisional suspension) until 22 May 2027. In addition, all the athlete’s competitive results as from 11 April 2025 are disqualified.
The decision may be challenged before the appeal division of the Court of Arbitration of Sport by the parties with a right of appeal in accordance with Article 13.2.3 of the WAKO anti-doping rules.
The ITA will not comment further on this case